1,000
Participants
Start Date
January 16, 2023
Primary Completion Date
November 1, 2028
Study Completion Date
November 1, 2028
total hysterectomy with bilateral salpingo-oophorectomy, lymph node staging and comprehensive peritoneal staging
"Surgical treatment will consist of total hysterectomy with bilateral salpingo-oophorectomy according to international guidelines.~In low- and intermediate-risk EC patients, staging will include a sentinel lymph node (SLN) procedure. In high intermediate-risk and high-risk EC patients, lymph node staging will involve SLN procedure and/or pelvic and para-aortic lymph node dissection (LND), depending on the local protocol.~The Study-related procedures include infracolic omentectomy or two separate omental representative biopsies, biopsies of all suspicious lesions as well as six peritoneal sites (bladder, pouch of Douglas, bilateral paracolic gutter and bilateral diaphragm).~Stage IV patients will be treated according to European guidelines. When feasible, full surgical intervention (i.e. debulking) is recommended. If this cannot be achieved, a radiologic and/or histologic confirmation of tumor spread beyond the uterus will be accepted."
RECRUITING
UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
University Medical Centre Maribor
OTHER
University Hospital, Gasthuisberg
OTHER